| References |
| Formal Name |
(1-butyl-2,2,3,3,4,4,4-d7-2-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone |
| Molecular Formula |
C23H14D7NO2 |
| Formula Weight |
350.5 |
| Formulation |
A solution in methanol |
| Purity |
≥99% deuterated product |
| Stability |
1 year |
| Storage |
-20°C |
| Shipping |
Wet ice
in continental US; may vary elsewhere
|
| SMILES |
[2H]C(C(C([2H])([2H])[2H])([2H])[2H])([2H])CN1C2=CC=CC=C2C(C(C3=CC=CC4=C3C=CC=C4)=O)=C1O
|
| Size |
Global Purchasing |
| 100 µg |
|
| 500 µg |
|
| 1 mg |
|
| 5 mg |
|
Description
JWH 073 2-hydroxyindole metabolite-d7 contains seven deuterium atoms at the 2, 2’, 3, 3’, 4, 4, and 4 positions. It is intended for use as an internal standard for the quantification of JWH 073 2-hydroxyindole metabolite by GC- or LC-mass spectrometry (MS). JWH 073 2-hydroxyindole metabolite is a potential monohydroxylated urinary metabolite of JWH 073, a WIN 55212-2 derivative that is a mildly selective agonist of the peripheral cannabinoid receptor.
|
